The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2021 | Next steps in gastric cancer
Zev Wainberg, MD, University of California Los Angeles, Los Angeles, CA, discusses upcoming advances in gastric cancer, including a renewed interest in the FGFR signalling pathway on the heels of the FIGHT study (NCT03694522), and the importance of understanding overlapping biomarkers in gastric cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
